The treatment of cardiac fibroblast cultures with TGF-β did not impact T. cruzi levels of infection, as there were no significant differences in the percentage of infected cells or at the number of intracellular amastigotes (Supplemental Material, Figure S3). Here, TGFB1 is linked to infection.